ArticleAbdominal radiology (New York)2026
Diffusion kurtosis imaging in predicting pathological grade of intrahepatic cholangiocarcinoma: a preliminary study.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectiveTo investigate the diagnostic accuracy of diffusion kurtosis imaging (DKI) in predicting pathological grade of intrahepatic cholangiocarcinoma (ICC) preoperatively.
methodsThe study included 48 patients with ICC confirmed by histopathology (18 males, 30 females). The cohort comprised 24 moderately differentiated (G2, intermediate-grade) and 24 poorly differentiated (G3, high-grade) tumors. Preoperative MR examinations including DKI and diffusion-weighted imaging (DWI) were performed, and mean kurtosis (MK), mean diffusivity (MD), and apparent diffusion coefficient (ADC) values were measured. Diagnostic performance for predicting high-grade ICC via the receiver operating characteristic curve (ROC) was assessed. Logistic regression analyses were applied to assess the value of clinical and laboratory variables and diffusion parameters as risk factors for pathological grade.
resultsHigh-grade ICC demonstrated significantly higher MK (0.85 ± 0.15 vs. 0.59 ± 0.12) but lower MD (1.38 ± 0.48 vs. 2.15 ± 0.76 × 10⁻³ mm²/s) and ADC (0.98 ± 0.23 vs. 1.36 ± 0.39 × 10⁻³ mm²/s) than intermediate-grade tumors (all P < 0.001). MK demonstrated superior diagnostic performance (area under ROC curve (AUC) = 0.925) compared to MD (AUC = 0.818) and ADC (AUC = 0.806) (all P < 0.001). Univariate analysis identified tumor size, MK, MD and ADC as predictors. Multivariate analysis confirmed MK (OR: 3.321; 95% CI: 1.559-10.37; P < 0.001) as an independent predictor.
conclusionDKI-derived MK outperforms MD and DWI-based ADC in predicting high-grade ICC, and could serve as a non-invasive preoperative biomarker to guide clinical management.
Indexed as
Identifiers
41801374What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.